Certificate of Analysis
QUALITY ASSURANCE TEST ONLY - Not for retail sale

Sample Name:

Mota Mix 100

Infused, Solid Edible

Date Issued:

06/02/2023

Sum Cannabinoids 4.6200 mg/g
Total Cannabinoids 4.6200 mg/g
Total THC 4.2972 mg/g
Total CBD 0.0202 mg/g

Sample Information

Sample Details

Sample ID:230601Q011

Batch Number:

Cultivator / Manufacturer

Show Details

Distributor / Tested For

Show Details

Share

Easily share a link to this results page with your friends, followers, or business partners.

Cannabinoid Analysis - Summary

Sum of Cannabinoids: 4.6200 mg/g

Total Cannabinoids: 4.6200 mg/g

Total THC: 4.2972 mg/g

Total CBD: 0.0202 mg/g

Sum of Cannabinoids = Δ9-THC + THCa + CBD + CBDa + CBG + CBGa + THCV + THCVa + CBC + CBCa + CBDV + CBDVa + Δ8-THC + CBL + CBN

Total Cannabinoids = (Δ9-THC+0.877*THCa+Δ8-THC) + (CBD+0.877*CBDa) + (CBG+0.877*CBGa) + (THCV+0.877*THCVa) + (CBC+0.877*CBCa) + (CBDV+0.877*CBDVa) + CBL + CBN

Total THC/CBD is calculated using the following formulas to take into account the loss of a carboxyl group during the decarboxylation step:
Total THC = Δ9-THC + (THCa (0.877)) + Δ8-THC
Total CBD = CBD + (CBDa (0.877))

Sum of Cannabinoids: The concentration of each individual cannabinoid added together as they are, without accounting for decarboxylation. This measurement is of particular importance for certain cannabis products that are not intended to be heated prior to application or consumption.

Total Cannabinoids: The concentration of each acidic cannabinoid, multiplied by 0.877 to account for the loss of molecular mass that happens as it is converted to a neutral cannabinoid when heated. Then this calculated concentration is added to the concentrations of the corresponding neutral cannabinoid already present. This corrected data is of particular importance to both producers and consumers of products intended to be heated prior to application or consumption.

View Complete Test Results:

Tested by high-performance liquid chromatography with diode-array detection (HPLC-DAD).

†Analytes not part of our ISO/IEC 17025 scope of accreditation.

Method: LA-SOP-101 Cannabinoid Analysis by HPLC-DAD

Summary

Total Cannabinoids: 4.6200 mg/g

Total THC: 4.2972 mg/g

(Δ9-THC+0.877*THCa+Δ8-THC)

Total CBD: 0.0202 mg/g

(CBD+0.877*CBDa)

Total CBG: 0.1163 mg/g

Total CBG (CBG+0.877*CBGa)

Total THCV: 0.0610 mg/g

Total THCV (THCV+0.877*THCVa)

Total CBC: 0.0704 mg/g

Total CBC (CBC+0.877*CBCa)

Total CBDV: ND

Total CBDV (CBDV+0.877*CBDVa)

Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Cannabinoid Test Results

06/02/2023

Result Views

Swipe left on table to see additional columns

Compound LOD/LOQ
(mg/g)
Measurement
Uncertainty
(mg/g)
Result
(mg/g)
Result
(%)
Δ9 Tetrahydrocannabinol (Δ9THC) 0.0014 / 0.0042 ±0.02578 4.2972 0.42972
Cannabigerol (CBG) 0.0009 / 0.0028 ±0.00045 0.1163 0.01163
Cannabichromene (CBC) 0.0008 / 0.0025 ±0.00025 0.0704 0.00704
Tetrahydrocannabivarin (THCV) 0.0006 / 0.0021 ±0.00016 0.0610 0.00610
Cannabinol (CBN) 0.0005 / 0.0021 ±0.00012 0.0549 0.00549
Cannabidiol (CBD) 0.0010 / 0.0029 ±0.00008 0.0202 0.00202
Cannabicyclol (CBL)† 0.0013 / 0.0045 N/A ND ND
Cannabichromenic Acid (CBCa) 0.0005 / 0.0021 N/A ND ND
Cannabidivarin (CBDV) 0.0015 / 0.0046 N/A ND ND
Cannabidiolic Acid (CBDa) 0.0006 / 0.0021 N/A ND ND
Cannabigerolic Acid (CBGa) 0.0007 / 0.0022 N/A ND ND
Tetrahydrocannabinolic Acid (THCa) 0.0004 / 0.0021 N/A ND ND
Cannabidivarinic Acid (CBDVa) 0.0005 / 0.0021 N/A ND ND
Tetrahydrocannabivarinic Acid (THCVa) 0.0008 / 0.0023 N/A ND ND
∆8 Tetrahydrocannabinol (Δ8THC) 0.0010 / 0.0029 N/A ND ND
SUM OF CANNABINOIDS 4.6200 mg/g 0.46200%
Learn more

The cannabis plant contains dozens of active compounds called cannabinoids. These compounds are the primary contributors to the psychoactive effects of cannabis.

Cannabinoid testing determines the potency of a sample to aid in dosage considerations.

Your current browser is unsupported. Please install latest version of Firefox, Chrome or IE to view this site.